Creation of a Syncope Channel for Patients Admitted to the Emergency Department for Loss of Consc… (NCT06503653) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Creation of a Syncope Channel for Patients Admitted to the Emergency Department for Loss of Consciousness and Not Hospitalized: Etiological Predictivity (Before/After Study)
France52 participantsStarted 2024-03-31
Plain-language summary
The main aim of this study is to assess the value of creating a "syncope pathway" to optimize diagnostic performance in patients admitted to the emergency department for syncope and not hospitalized, compared with the previous pre-syncope pathway situation.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 and over;
* Consultant at the emergency department of the Centre Hospitalier de V ersailles
* For a confirmed diagnosis:
* of recurrent syncope with low-risk criteria according to ESC 2018 (1,2) Or
* of syncope recurrent or not, not fulfilling low-risk or high-risk criteria according to the ESC 2018 definition (1,2). These patients are those with minor high-risk criteria without aggravating circumstances:
* With no personal history of loss of consciousness whose clinical features strongly suggest syncope of rhythmic origin;
* No structural heart disease or abnormal ECG.
* Outpatient (returning home after emergency);
* Beneficiary or beneficiary of a social security scheme (excluding AME).
Exclusion Criteria:
* Etiology of syncope identified as early as the emergency department visit;
* High-risk syncope according to ESC 2018 criteria (1,3);
* First and only episode of low-risk syncope according to ESC 2018 criteria (1,3);
* Syncope of any risk category requiring hospitalization at the discretion of the emergency physician and cardiologist;
* Legal protection by guardianship ;
* Language barrier or condition incompatible with the patient's understanding or informed adherence to the protocol;
* Opposition to the use of their pseudonymized data (for retrospective inclusions);
* Patient's refusal to give consent to participate in the study (for prospective inclusions);